Actively Recruiting
Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Led by Women and Infants Hospital of Rhode Island · Updated on 2024-09-20
150
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this randomized control trial is to assess if prenatal vaccine education and in-office vaccination administration for non-birthing partners of pregnant patients increases Tdap vaccination rates compared to usual care. The main question\[s\] it aims to answer are: * To assess whether compared to standard prenatal care, targeted prenatal education regarding Tdap vaccination recommendations with and without in office vaccination opportunities improves Tdap uptake among non-birthing partners of pregnant patients. * To assess whether non-birthing partners presenting for Tdap vaccination are willing to accept dual vaccination with Tdap and influenza. Participants will receive direct verbal and written education at the time of enrollment on cocooning and recommendation for partner Tdap vaccination prior to delivery with or without the option to receive Tdap at their convenience at the WIH obstetric care clinic. If there is a comparison group: Researchers will compare "Upfront Education" and "Upfront Education and Vaccination Administration" to "Usual care" to see if education and/or the offer for vaccination in the office increases Tdap vaccine acceptance for non-birthing partners.
CONDITIONS
Official Title
Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be the partner of a pregnant patient receiving prenatal care at the OGCC
- Be between 19 and 50 years old
- Have not received or be unsure if you received the adult Tdap vaccine or booster in the last 10 years
- Be fluent in English or Spanish
You will not qualify if you...
- Have a latex allergy
- Have a lethal fetal anomaly diagnosed before enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Women and Infants Hospital
Providence, Rhode Island, United States, 02920
Actively Recruiting
Research Team
L
Laurie Griffin, MD/PhD
CONTACT
A
Adam Lewkowitz, MD/MPHS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here